Asensus Surgical Inc (ASXC)

1.605
-0.065(-3.89%)
  • Volume:
    7,961,122
  • Bid/Ask:
    1.60/1.63
  • Day's Range:
    1.54 - 1.81

ASXC Overview

Prev. Close
1.67
Day's Range
1.54 - 1.81
Revenue
3.18M
Open
1.69
52 wk Range
0.3 - 6.95
EPS
-1.15
Volume
7,961,122
Market Cap
371.93M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
14,536,539
P/E Ratio
-
Beta
1.66
1-Year Change
265.59%
Shares Outstanding
233,186,653
Next Earnings Date
Aug 11, 2021
What is your sentiment on Asensus Surgical Inc?
or
Market is currently closed. Voting is open during market hours.

Asensus Surgical Inc News

  • DRYS, ROKU among premarket gainers
    • BySeeking Alpha-

    Axsome Therapeutics (NASDAQ:AXSM) +20% on raising $23.3M (NYSE:MMM) under existing ATM facility.Pyxis Tankers (NASDAQ:PXS) +13%.Taoping (NASDAQ:TAOP) +11% to acquire 51% of...

  • Premarket Gainers as of 9:05 am (05/09/2018)
    • BySeeking Alpha-

    DCIX +69% on Q1 result. QUMU +22% on receiving $1M in cloud license fees. TRIP +18% on Q1 result. AAXN +12% on Q1 result. TRXC +11% on Q1 result. EPE +11% on Q1...

Asensus Surgical Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsBuySellStrong SellStrong SellSell
SummaryNeutralSellStrong SellStrong SellStrong Sell

Asensus Surgical Inc Company Profile

Asensus Surgical Inc Company Profile

Asensus Surgical, Inc., formerly TransEnterix, Inc., is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. Its System is designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, advanced instrumentation, including three-millimeter micro laparoscopic instruments, eye-sensing camera control and reusable standard instruments to patients around the world. The Senhance System is used in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.

Read More
  • Evofem Biosciences EVFM Receives Fast Track Designation for EVO100 for Prevention of Gonorrhea in Women
    0
    • Such an awesome long one here. 🚀🔥🍾
      0
      • Time to the moon
        1
        • just bought 696 more shares@1.74!🚀🚀🚀🚀
          0
          • Financial results are tomorrow, looks like that is causing some profit taking
            0
        • anyone know the pump that will take place tomorrow?
          1
          • Howd that pump go
            0
        • Hold the line!
          0
          • yeeeah!
            0
            • At this price it’s a robbery: 4th of may 1,87. Bought extra shares
              0
              • Ok!1,30
                2
            • At this price it's a steal: 3rth of may 1,995
              0
              • why this is red
                0
                • 🚀🚀🚀
                  0
                  • U will see it above 20$ EOY
                    1
                    • Bryan Kregerlets see and try our luck
                      0
                    • Keith Lin this case we will have party
                      0
                    • fingers crossed :)
                      0
                  • Going down....
                    7
                    • The calm before the storm?
                      3
                      • green again
                        1
                        • ASXC is a stock that clearly paving the way to be a millionaire in 5 years.
                          1
                          • I agree with u
                            0
                        • Head fake. Will go back down to $1.20. Sorry
                          17
                          • yes, v-shape👍
                            1
                            • yesssss!
                              0
                              • another 100% and I'm on 0
                                0
                              • me toο!
                                0
                            • buy buy buy
                              0
                              • YEEES!!!!
                                0
                                • Is there any reason to +18 today?
                                  0
                                  • when the price was too high you had to worry, when the price is lower the panic should go away. a stock is the most dangerous when at ATH, the short positions of the funds will soon expire. buy & hold it's a good position to enter
                                    2
                                    • just hold
                                      0
                                      • delete the app
                                        0
                                      • 0
                                      • Alexandru Chisălcahope u still hold it and forgot ur pain
                                        0
                                    • -12 at 1,54.... mm200 at 1,54... ready or no?
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.